Christopher Sarchi
Corporate Officer/Principal at REPLIMUNE GROUP, INC.
Net worth: 830 268 $ as of 2024-06-29
Profile
Christopher Sarchi is currently the Chief Commercial Officer at Replimune Group, Inc. He previously worked as the Director-Oncology Regional Sales at Genentech, Inc. from 2010 to 2013.
He also held the position of Head-Commercial Oncology US Region at Sanofi.
Mr. Sarchi completed his undergraduate degree at the University of Maine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0.15% | 2024-05-15 | 92,252 ( 0.15% ) | 830 268 $ | 2024-06-29 |
Christopher Sarchi active positions
| Companies | Position | Start |
|---|---|---|
| REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 2023-01-02 |
Former positions of Christopher Sarchi
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2012-12-31 |
| SANOFI | Corporate Officer/Principal | - |
Training of Christopher Sarchi
| University of Maine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| SANOFI | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Christopher Sarchi
